Literature DB >> 24816174

Hepcidin knockout mice fed with iron-rich diet develop chronic liver injury and liver fibrosis due to lysosomal iron overload.

Mariia Lunova1, Claudia Goehring1, Deniz Kuscuoglu2, Katrin Mueller1, Yu Chen1, Paul Walther3, Jean-Christophe Deschemin4, Sophie Vaulont4, Johannes Haybaeck5, Carolin Lackner5, Christian Trautwein2, Pavel Strnad6.   

Abstract

BACKGROUND & AIMS: Hepcidin is the central regulator of iron homeostasis and altered hepcidin signalling results in both hereditary and acquired iron overload. While the association between iron overload and development of end-stage liver disease is well established, the underlying mechanisms are largely unknown. To improve that, we analysed hepcidin knockout (KO) mice as a model of iron overload-associated liver disease.
METHODS: Hepcidin wild type (WT) and KO mice fed with 3% carbonyl iron-containing diet starting at one month of age were compared to age-matched animals kept on standard chow. Liver histology and serum parameters were used to assess the extent of liver injury and fibrosis. Iron distribution was determined by subcellular fractionation and electron microscopy.
RESULTS: Among mice kept on iron-rich diet, 6 months old hepcidin KO mice (vs. WT) displayed profound hepatic iron overload (3,186 ± 411 vs. 1,045 ± 159 μg/mg tissue, p<0.005), elevated liver enzymes (ALT: KO 128 ± 6, WT 56 ± 5 IU/L, p<0.05), mild hepatic inflammation and hepatocellular apoptosis. Twelve, but not six months old KO mice fed with iron-rich diet developed moderate liver fibrosis. The liver injury was accompanied by a marked lysosomal iron overload and lysosomal fragility with release of cathepsin B into the cytoplasm. Increased p62 levels and autofluorescent iron complexes suggested impaired protein degradation. As a mechanism leading to lysosomal iron overload, the autophagy (lysosomal influx) was increased.
CONCLUSIONS: Hepcidin KO mice represent a novel model of iron overload-related liver diseases and implicate lysosomal injury as a crucial event in iron toxicity.
Copyright © 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Hemochromatosis; Inflammation

Mesh:

Substances:

Year:  2014        PMID: 24816174     DOI: 10.1016/j.jhep.2014.04.034

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  23 in total

1.  Ablation of Hepatocyte Smad1, Smad5, and Smad8 Causes Severe Tissue Iron Loading and Liver Fibrosis in Mice.

Authors:  Chia-Yu Wang; Xia Xiao; Abraham Bayer; Yang Xu; Som Dev; Susanna Canali; Anil V Nair; Ricard Masia; Jodie L Babitt
Journal:  Hepatology       Date:  2019-08-13       Impact factor: 17.425

Review 2.  Iron and Neurodegeneration: Is Ferritinophagy the Link?

Authors:  Giorgio Biasiotto; Diego Di Lorenzo; Silvana Archetti; Isabella Zanella
Journal:  Mol Neurobiol       Date:  2015-10-14       Impact factor: 5.590

3.  Lack of hepcidin expression attenuates steatosis and causes fibrosis in the liver.

Authors:  Sizhao Lu; Robert G Bennett; Kusum K Kharbanda; Duygu Dee Harrison-Findik
Journal:  World J Hepatol       Date:  2016-02-08

4.  The hepatocyte-specific HNF4α/miR-122 pathway contributes to iron overload-mediated hepatic inflammation.

Authors:  Min Li; Yuxiao Tang; Lusha Wu; Fengfeng Mo; Xin Wang; Hongxia Li; Ruirui Qi; Hongwei Zhang; Arun Srivastava; Chen Ling
Journal:  Blood       Date:  2017-06-27       Impact factor: 22.113

5.  Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells.

Authors:  Kyle A Bauckman; Indira U Mysorekar
Journal:  Autophagy       Date:  2016-05-03       Impact factor: 16.016

6.  Iron overload by Superparamagnetic Iron Oxide Nanoparticles is a High Risk Factor in Cirrhosis by a Systems Toxicology Assessment.

Authors:  Yushuang Wei; Mengzhu Zhao; Fang Yang; Yang Mao; Hang Xie; Qibing Zhou
Journal:  Sci Rep       Date:  2016-06-30       Impact factor: 4.379

7.  Cationic PEGylated liposomes incorporating an antimicrobial peptide tilapia hepcidin 2-3: an adjuvant of epirubicin to overcome multidrug resistance in cervical cancer cells.

Authors:  Vivian Juang; Hsin-Pin Lee; Anya Maan-Yuh Lin; Yu-Li Lo
Journal:  Int J Nanomedicine       Date:  2016-11-15

8.  Distinct Murine Pancreatic Transcriptomic Signatures during Chronic Pancreatitis Recovery.

Authors:  Yinjie Zhang; Baibing Yang; Joy M Davis; Madeline M Drake; Mamoun Younes; Qiang Shen; Zhongming Zhao; Yanna Cao; Tien C Ko
Journal:  Mediators Inflamm       Date:  2021-05-15       Impact factor: 4.711

9.  Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.

Authors:  M Lunova; S Frankova; H Gottfriedova; R Senkerikova; M Neroldova; J Kovac; E Kieslichova; V Lanska; E Sticova; J Spicak; M Jirsa; J Sperl
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

10.  Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis.

Authors:  Tiago L Duarte; Carolina Caldas; Ana G Santos; Sandro Silva-Gomes; Andreia Santos-Gonçalves; Maria João Martins; Graça Porto; José Manuel Lopes
Journal:  Redox Biol       Date:  2016-12-01       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.